One Symptom. Each Treatment Category.

Snoring is not a single disease — it is a universal symptom that serves as the first clinical signal for a broad spectrum of conditions ranging from obstructive sleep apnea and obesity to type 2 diabetes, hypertension, cardiovascular disease, fatty liver disease, and chronic kidney disease. Each of these conditions has its own treatment ecosystem, its own prescribing physicians, its own device and pharmaceutical pipeline, and its own patient journey to a cure.

The Snoring Funnel is the strategic framework that captures patients at the earliest, highest-volume point of that journey — the moment they search for help with their snoring — and routes them through evidence-based risk stratification toward the appropriate treatment pathway. Because snore.com sits at the top of this funnel with 30 years of semantic authority, it represents a uniquely powerful unbranded marketing asset applicable across every major treatment category simultaneously.

The funnel model illustrated below uses the pharmaceutical and incretin market as its primary example. However, the same funnel architecture applies with equal strategic logic to CPAP and respiratory devices, oral appliances, neurostimulators, smart beds and sleep technology, pharmacy chains and affiliated clinics, telehealth platforms, and consumer healthcare products — any vendor whose patient population includes snorers, which is to say, virtually every major player in cardiometabolic and sleep medicine.